Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
'Several concerning observations': FDA sheds light on rejections
The FDA’s ongoing effort to establish a culture of “radical transparency” saw the agency publish another haul of complete response letters yesterday.
James Waldron
Sep 5, 2025 10:45am
Fierce Pharma
Fierce 50 of 2025
Sep 2, 2025 4:30am
Senseonics to retake Eversense commercial control from Ascensia
Sep 5, 2025 2:00pm
Medtronic’s Hugo robot logs success in hernia repair trial
Sep 5, 2025 12:00pm
Braveheart pays $65M to challenge BMS for heart disease market
Sep 5, 2025 9:05am
Merck KGaA lands new R&D chief—Chutes & Ladders
Sep 5, 2025 8:30am
More News
BioNTech's ADC beats Roche’s Kadcyla in breast cancer phase 3
Sep 5, 2025 7:30am
Fierce Biotech Fundraising Tracker: MRM Health, Treeline & more
Sep 4, 2025 4:15pm
Fierce Pharma
RFK Jr. blasts pharma industry, touts mRNA vaccine misinformation
Sep 4, 2025 3:51pm
FDA plans real-time release of drug rejection letters
Sep 4, 2025 1:45pm
See more stories